IgM and IgG antibodies binding to allogeneic tumors enabled tumor-infiltrating DCs to process and present tumor antigens to CD4+ T cells, and this response was abrogated in FcγR-deficient mice. This evidence concerns the gene FCGR2A and neoplasm.